Alkem Arise Online Quiz December'17
-
The composition of Esokem D is:
-
Esomeprazole 40 mg + Domperidone 30 mg SR Capsule
-
Esomeprazole 40 mg + Domperidone 30 mg SR Tablet
-
Esomeprazole 40 mg + Domperidone 20 mg SR Capsule
-
Esomeprazole 40 mg + Domperidone 20 mg SR Tablet
-
The Alkem Arise Online Quiz December'17 assesses knowledge on the composition and release technology of Esokem medications. It focuses on the specifics of Esomeprazole and Domperidone in Esokem D, and Esomeprazole with Levosulpiride in Esokem L, including INTEL technology applications.
Quiz Preview
- 2.
The composition of Esokem L is:
-
Esomeprazole 40 mg + Levosulpiride 75 mg SR Tablet
-
Esomeprazole 40 mg + Levosulpiride 75 mg SR Capsule
-
Esomeprazole 40 mg + Levosulpiride 70 mg SR Tablet
-
Esomeprazole 40 mg + Levosulpiride 70 mg SR Capsule
Correct Answer
A. Esomeprazole 40 mg + Levosulpiride 75 mg SR CapsuleExplanation
The correct answer is Esomeprazole 40 mg + Levosulpiride 75 mg SR Capsule. This is because the composition of Esokem L is a combination of Esomeprazole and Levosulpiride in a sustained-release capsule form, with Esomeprazole at a dosage of 40 mg and Levosulpiride at a dosage of 75 mg. The other options listed do not match this specific composition.Rate this question:
-
- 3.
INTEL Technology in Esokem-L ensures Esomeprazole pellets release in:
-
Stomach
-
50% release in Stomach & 50% release in Duodenum
-
Duodenum
-
80% release in Stomach & 20% release in Duodenum
Correct Answer
A. DuodenumExplanation
INTEL Technology in Esokem-L ensures that the release of Esomeprazole pellets occurs primarily in the duodenum. This means that a majority of the medication is released in the duodenum, which is the first part of the small intestine, rather than in the stomach. This targeted release helps to optimize the absorption and effectiveness of the medication in the intended area of the digestive system.Rate this question:
-
- 4.
INTEL Technology in Esokem-L ensures Levosulpiride SR pellets release in:
-
Stomach
-
50% release in Stomach & 50% release in Duodenum
-
Duodenum
-
80% release in Stomach & 20% release in Duodenum
Correct Answer
A. StomachExplanation
The correct answer is "Stomach." This means that the INTEL Technology in Esokem-L ensures that Levosulpiride SR pellets are released primarily in the stomach.Rate this question:
-
- 5.
In Esokem-L outer EAMA coating ensures:
-
Totally Non-permeable to Stomach Acid
-
Protects against acidic medium of Stomach
-
Protects against moisture
-
Both (a) & (b)
Correct Answer
A. Both (a) & (b)Explanation
The correct answer is "Both (a) & (b)". The outer EAMA coating in Esokem-L provides protection against the acidic medium of the stomach, as well as being totally non-permeable to stomach acid. Additionally, it also protects against moisture. Therefore, both options (a) and (b) are correct.Rate this question:
-
- 6.
In Esokem-L Inner:Hypromellose Sodium coating ensures:
-
Totally Non-permeable to Stomach Acid
-
Protects against acidic medium of Stomach
-
Protects against moisture
-
Both (a) & (b)
Correct Answer
A. Protects against moistureExplanation
The correct answer is "Protects against moisture". The Esokem-L Inner coating, which contains Hypromellose Sodium, acts as a barrier that protects the medication from moisture. This is important because moisture can affect the stability and effectiveness of the medication. By preventing moisture from reaching the drug, the coating helps to maintain its quality and potency.Rate this question:
-
- 7.
Esokem-L is available as Dual Pellets:
-
True
-
False
Correct Answer
A. TrueExplanation
Esokem-L is available as Dual Pellets, which means that it is formulated in the form of pellets. The term "dual" suggests that it contains two active ingredients or components. This form of medication is designed to release the active ingredients in a controlled manner, providing a sustained release of the medication over a longer period of time. The availability of Esokem-L as Dual Pellets provides patients with an option for convenient and effective treatment.Rate this question:
-
- 8.
Esokem-L Capsule Shell is Translucent:
-
True
-
False
Correct Answer
A. FalseExplanation
The given statement is "Esokem-L Capsule Shell is Translucent" and the correct answer is "False." This means that the Esokem-L capsule shell is not translucent.Rate this question:
-
- 9.
Esokem-L is available as Dual Pellets. The colour of Esomeprazole is:
-
White
-
Yellow
-
Blue
-
Green
Correct Answer
A. BlueExplanation
Esomeprazole, which is available as Dual Pellets in the form of Esokem-L, is blue in color.Rate this question:
-
- 10.
Esokem-L is available as Dual Pellets. The colour of Levosulpiride is:
-
Blue
-
Yelow
-
White
-
Green
Correct Answer
A. WhiteExplanation
Levosulpiride, which is available as Dual Pellets under the brand name Esokem-L, is white in color.Rate this question:
-
- 11.
The Dual Coating of Esokem-L ensures “Zero” Degradation:
-
True
-
False
Correct Answer
A. TrueExplanation
The statement suggests that the Dual Coating of Esokem-L guarantees that there will be no degradation. This means that the coating is designed to protect the material from any form of deterioration or damage, ensuring its quality and performance over time.Rate this question:
-
- 12.
The indication of Esokem is:
-
In Functional Dyspepsia & Refractory GERD
-
In GERD & Dyspepsia associated with Nausea & Vomiting
-
Both (a) & (b)
-
In APDs, Gastritis & Hyperacidity
Correct Answer
A. In APDs, Gastritis & HyperacidityExplanation
Esokem is indicated for the treatment of APDs (Acid Peptic Disorders) such as gastritis and hyperacidity. This means that Esokem is used to alleviate symptoms related to excessive acid production in the stomach, including conditions like gastritis and hyperacidity. It is not indicated for functional dyspepsia, refractory GERD, or GERD and dyspepsia associated with nausea and vomiting.Rate this question:
-
- 13.
The indication of Esokem-D is:
-
In Functional Dyspepsia & Refractory GERD
-
In APDs, Gastritis & Hyper-acidity
-
Both (a) & (b)
-
In GERD & Dyspepsia associated with Nausea & Vomiting
Correct Answer
A. In GERD & Dyspepsia associated with Nausea & VomitingExplanation
The indication of Esokem-D is in GERD & Dyspepsia associated with Nausea & Vomiting. This means that Esokem-D is recommended for the treatment of gastroesophageal reflux disease (GERD) and dyspepsia (indigestion) that is accompanied by symptoms of nausea and vomiting. It may not be effective or recommended for other conditions such as functional dyspepsia, refractory GERD, APDs, gastritis, or hyper-acidity.Rate this question:
-
- 14.
The indication of Esokem-L is:
-
In GERD & Dyspepsia associated with Nausea & Vomiting
-
In APDs, Gastritis & Hyperacidity
-
Both (a) & (b)
-
In Functional Dyspepsia & Refractory GERD
Correct Answer
A. In Functional Dyspepsia & Refractory GERDExplanation
The indication of Esokem-L is in Functional Dyspepsia & Refractory GERD. This means that Esokem-L is recommended for use in patients who have functional dyspepsia, which is a condition characterized by recurring indigestion and pain in the upper abdomen, and also in patients who have refractory GERD, which refers to gastroesophageal reflux disease that does not respond to standard treatment. Esokem-L may help alleviate symptoms and provide relief in these conditions.Rate this question:
-
- 15.
“An Ideal PPI that Completes your Presciption” is punch line for:
-
Esokem
-
Esokem-D
-
Esokem-L
-
All of the Above
Correct Answer
A. All of the AboveExplanation
The punch line "An Ideal PPI that Completes your Prescription" is applicable to all three options: Esokem, Esokem-D, and Esokem-L. This suggests that all these products are considered ideal proton pump inhibitors (PPIs) that can effectively complete a prescription.Rate this question:
-
- 16.
Which among the following is correct for Rifakem
-
Non-aminoglycoside semi-synthetic, systemic antibiotic
-
Aminoglycoside semi-synthetic, non-systemic antibiotic
-
Non-aminoglycoside natural, systemic antibiotic
-
Non-aminoglycoside semi-synthetic, non-systemic antibiotic
Correct Answer
A. Non-aminoglycoside semi-synthetic, non-systemic antibioticExplanation
Rifakem is classified as a non-aminoglycoside semi-synthetic, non-systemic antibiotic. This means that it is a type of antibiotic that is not derived from the aminoglycoside class of drugs. It is also a semi-synthetic antibiotic, which means that it is partially synthesized in the laboratory using natural or semi-synthetic compounds. Additionally, Rifakem is non-systemic, meaning that it does not have a widespread effect throughout the body and is typically used to treat localized infections.Rate this question:
-
- 17.
Rifakem offers
-
Lower Glucose Breath normalization rate & decontamination rate
-
Higher Glucose Breath normalization rate & contamination rate
-
Higher Glucose Breath normalization rate & decontamination rate
-
Lower Glucose Breath normalization rate & contamination rate
Correct Answer
A. Higher Glucose Breath normalization rate & decontamination rateExplanation
The correct answer is "Higher Glucose Breath normalization rate & decontamination rate". This means that Rifakem offers a higher rate of normalizing glucose breath levels and a higher rate of decontamination. This suggests that Rifakem is effective in reducing glucose levels in the breath and in removing contaminants.Rate this question:
-
- 18.
Rifaximin acts by binding to the beta sub-unit of bacterial DNA dependent RNA polymerase resulting in …………………………………..
-
Inhibition of bacterial DNA synthesis
-
Inhibition of bacterial RNA synthesis
Correct Answer
A. Inhibition of bacterial RNA synthesisExplanation
Rifaximin acts by binding to the beta sub-unit of bacterial DNA dependent RNA polymerase. This binding prevents the enzyme from synthesizing RNA, leading to the inhibition of bacterial RNA synthesis. As a result, the bacteria are unable to produce essential proteins and ultimately cannot survive or replicate. This mechanism of action makes rifaximin an effective antibiotic for treating bacterial infections.Rate this question:
-
- 19.
Packing advantage of Low Density Polyethylene in Novogermina ensures
-
Novogermina can sustain a temperature of 50 degree Celsius
-
Novogermina can sustain a temperature of 45 degree Celsius
-
Novogermina can sustain a temperature of 110 degree Celsius
-
Novogermina can sustain a temperature of 55 degree Celsius
Correct Answer
A. Novogermina can sustain a temperature of 110 degree Celsius -
- 20.
Novogermina can sustain a temperature of 55 degree Celsius
-
UBBC 05
-
UBBC 01
-
UBBC 07
-
UBBC 02
Correct Answer
A. UBBC 07Explanation
UBBC 07 is the correct answer because it suggests that Novogermina has the ability to withstand a temperature of 55 degrees Celsius. This indicates that Novogermina has a high heat tolerance and can maintain its stability and effectiveness even at high temperatures.Rate this question:
-
Quiz Review Timeline (Updated): Mar 21, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
-
Current Version
-
Mar 21, 2023Quiz Edited by
ProProfs Editorial Team -
Dec 08, 2017Quiz Created by
Arise
Back to top